ICER developed a report on Active Surveillance and Radical Prostatectomy for prostate cancer.

Prostate cancer is the second leading cause of cancer deaths and the seventh overall cause
of death in men in the United States (Centers for Disease Control and Prevention, 2008).
Given that most new cases are diagnosed at an early, localized stage, significant attention
has been focused on understanding the risks and benefits of alternative management
strategies for patients with low-risk disease. The major options include active surveillance
and various forms of radiation therapy and surgery. Most men in the United States choose
one of the definitive forms of treatment, but data to compare the long-term risks and
benefits of active surveillance and each of the definitive treatment options are limited,
placing great emphasis on the need for objective sources of guidance to help clinicians and
patients engage in active shared decision-making

Date of Review: September 2009

For questions or additional information, please contact

Final Documents

Below you will find the final documents from the assessment review process: